Skip Nav Destination
CONTINUING MEDICAL EDUCATION (CME) QUESTIONS|
August 18, 2022
Outcomes for adenosine deaminase–deficient SCID
CME
Blood (2022) 140 (7): 795.
Article history
Submitted:
July 7, 2022
Accepted:
July 7, 2022
Connected Content
A related article has been published:
Outcomes following treatment for ADA-deficient severe combined immunodeficiency: a report from the PIDTC
Citation
Outcomes for adenosine deaminase–deficient SCID. Blood 2022; 140 (7): 795. doi: https://doi.org/10.1182/blood.2022017722
Download citation file:
August 18 2022
Advertisement intended for health care professionals
Cited By
Advertisement intended for health care professionals
This feature is available to Subscribers Only
Sign In or Create an Account Close Modal